Kristin L. Mekeel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kristin L. Mekeel has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Adyr A. Moss
Division of Transplant, Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Phoenix, AZ 85054, USA
4 shared publicationsDavid C. Mulligan
Division of Transplant, Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Phoenix, AZ 85054, USA
4 shared publicationsR. L. Heilman
Division of Transplant Nephrology, Mayo Clinic, Phoenix, AZ 85054, USA
3 shared publicationsA. A. Moss
Division of Transplantation, Hepatobiliary and Pancreatic Surgery, Department of Surgery
2 shared publicationsAdyr Moss
Division of Transplant Surgery, Mayo Clinic Hospital, Phoenix, AZ
2 shared publicationsD. C. Mulligan
Division of Transplantation, Hepatobiliary and Pancreatic Surgery, Department of Surgery
2 shared publications
Latest Publications
- Open Access
- 25 March 2010
- Published by Hindawi Limited in Journal of Transplantation
- Vol. 2010, 1-5
Successful Transplantation of a Split Crossed Fused Ectopic Kidney into a Patient with End-Stage Renal Disease
Potential donors with congenital renal anomalies but normal renal function are often overlooked because of a possible increase in technical difficulty and complications associated with the surgery. However, as the waiting list for a deceased donor kidney transplant continues to grow, it is important to consider these kidneys for potential transplant. This paper describes the procurement of a crossed fused ectopic kidney, and subsequent parenchymal transection prior to transplantation as part of a combined simultaneous kidney pancreas transplant. The transplant was uncomplicated, and the graft had immediate function. The patient is now two years from transplant with excellent function.
- 25 March 2010
- Published by Hindawi Limited in Journal of Transplantation
- Vol. 2010, 1-5
Open AccessSuccessful Transplantation of a Split Crossed Fused Ectopic Kidney into a Patient with End-Stage Renal Disease
Potential donors with congenital renal anomalies but normal renal function are often overlooked because of a possible increase in technical difficulty and complications associated with the surgery. However, as the waiting list for a deceased donor kidney transplant continues to grow, it is important to consider these kidneys for potential transplant. This paper describes the procurement of a crossed fused ectopic kidney, and subsequent parenchymal transection prior to transplantation as part of a combined simultaneous kidney pancreas transplant. The transplant was uncomplicated, and the graft had immediate function. The patient is now two years from transplant with excellent function.
- Open Access
- 1 September 2009
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (7) , 1666-1670
Deceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to Rhabdomyolysis
- 1 September 2009
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (7) , 1666-1670
Open AccessDeceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to Rhabdomyolysis
- 1 April 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (4) , 435-439
Sclerosing peritonitis and mortality after liver transplantation
Sclerosing peritonitis describes the development of a peel or rind of fibrosis that spreads over the peritoneal surface and can lead to recalcitrant ascites, bowel obstruction, and sepsis. It is well described as a complication of peritoneal dialysis, especially with episodes of bacterial peritonitis. It is also a complication of end-stage liver disease with ascites and liver transplantation. This article describes 3 cases of sclerosing peritonitis present at the time of liver transplantation or soon after. All 3 patients had massive refractory ascites with episodes of spontaneous bacterial peritonitis prior to transplantation. Two patients had evidence of a fibrous peel at the time of transplantation. Postoperatively, all 3 patients continued to have refractory ascites and episodes of peritonitis, along with partial small bowel obstructions, abdominal pain, and malnutrition. Two patients also had constriction of the graft, including biliary obstruction and inferior vena cava and outflow obstruction, which has not been previously described. All 3 patients eventually died from complications related to the sclerosing peritonitis.
- 1 April 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (4) , 435-439
Sclerosing peritonitis and mortality after liver transplantation
Sclerosing peritonitis describes the development of a peel or rind of fibrosis that spreads over the peritoneal surface and can lead to recalcitrant ascites, bowel obstruction, and sepsis. It is well described as a complication of peritoneal dialysis, especially with episodes of bacterial peritonitis. It is also a complication of end-stage liver disease with ascites and liver transplantation. This article describes 3 cases of sclerosing peritonitis present at the time of liver transplantation or soon after. All 3 patients had massive refractory ascites with episodes of spontaneous bacterial peritonitis prior to transplantation. Two patients had evidence of a fibrous peel at the time of transplantation. Postoperatively, all 3 patients continued to have refractory ascites and episodes of peritonitis, along with partial small bowel obstructions, abdominal pain, and malnutrition. Two patients also had constriction of the graft, including biliary obstruction and inferior vena cava and outflow obstruction, which has not been previously described. All 3 patients eventually died from complications related to the sclerosing peritonitis.
- 1 March 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (3) , 350-351
Hemobilia and pancreatitis after liver transplant biopsy
- 1 March 2009
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 15 (3) , 350-351
Hemobilia and pancreatitis after liver transplant biopsy
- 1 October 2008
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 18 (5) , 511-513
Laparoscopic Fenestration of Giant Hepatic Cysts
Laparoscopic fenestration has become the standard of care for nonparasitic cysts of the liver, both solitary and multiple. In this case report, we describe the laparoscopic fenestration of 2 giant hepatic cysts that were greater than 25 cm in largest diameter, and resulted in significant compression of adjacent structures, including the biliary tree and inferior vena cava. In particular, the technical considerations of port placement and cyst wall removal will be addressed.
- 1 October 2008
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 18 (5) , 511-513
Laparoscopic Fenestration of Giant Hepatic Cysts
Laparoscopic fenestration has become the standard of care for nonparasitic cysts of the liver, both solitary and multiple. In this case report, we describe the laparoscopic fenestration of 2 giant hepatic cysts that were greater than 25 cm in largest diameter, and resulted in significant compression of adjacent structures, including the biliary tree and inferior vena cava. In particular, the technical considerations of port placement and cyst wall removal will be addressed.
- Open Access
- 23 April 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (5) , 680-683
Living donor liver transplantation in polycystic liver disease
In the current Model for End-Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved. Traditionally, a caval resection has been advocated in these patients because of the difficulty of the hepatectomy with hepatomegaly, which makes living donation impossible. This series looks at 3 patients who underwent a caval sparing hepatectomy and subsequent living donor liver transplantation (LDLT) for PCLD. Graft and patient survival was 100%, and there were few complications in either donors or recipients. LDLT is an ideal option for patients with PCLD and preserved liver function but poor quality of life. Liver Transpl 14:680–683, 2008. © 2008 AASLD.
- 23 April 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (5) , 680-683
Open AccessLiving donor liver transplantation in polycystic liver disease
In the current Model for End-Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved. Traditionally, a caval resection has been advocated in these patients because of the difficulty of the hepatectomy with hepatomegaly, which makes living donation impossible. This series looks at 3 patients who underwent a caval sparing hepatectomy and subsequent living donor liver transplantation (LDLT) for PCLD. Graft and patient survival was 100%, and there were few complications in either donors or recipients. LDLT is an ideal option for patients with PCLD and preserved liver function but poor quality of life. Liver Transpl 14:680–683, 2008. © 2008 AASLD.
- 1 November 2007
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (11) , 1576-1581
Laparoscopic incisional hernia repair after liver transplantation
Incisional hernias occur in up to 17% of patients after liver transplantation. Laparoscopic ventral hernia repair is associated with fewer wound complications and a decreased incidence of recurrence when compared to open hernia repair in nontransplant patients. This is a retrospective review of 13 patients who underwent laparoscopic incisional hernia repair (LAP group) after liver transplantation compared to 14 patients who had open repairs (OP group; all but one with mesh). Primary immunosuppression in both groups at the time of transplantation was tacrolimus, but more patients in the LAP group were on sirolimus at the time of hernia, while more patients in the OP group were on prednisone at the time of hernia repair. All operations were completed with a laparoscopic approach; there were no conversions to open. Length of stay differed significantly between the 2 groups, with a mean of 5.4 days for the LAP group compared to 2.7 days in the OP group (0.0059). Complications occurred in 2 (15%) of the patients in the LAP group and 5 (36%) in the OP group. One patient in the LAP group required mesh removal to exclude causes of recurrent ascites, and 1 in the OP group for mesh infection. One (7.6%) of the patients in the LAP group developed a recurrence, compared to 29% (4) of the OP group (P =0.3259). In conclusion, laparoscopic incisional hernia repair is safe in patients after liver transplantation, with a low risk of infection or recurrence. Liver Transpl 13:1576–1581, 2007. © 2007 AASLD.
- 1 November 2007
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (11) , 1576-1581
Laparoscopic incisional hernia repair after liver transplantation
Incisional hernias occur in up to 17% of patients after liver transplantation. Laparoscopic ventral hernia repair is associated with fewer wound complications and a decreased incidence of recurrence when compared to open hernia repair in nontransplant patients. This is a retrospective review of 13 patients who underwent laparoscopic incisional hernia repair (LAP group) after liver transplantation compared to 14 patients who had open repairs (OP group; all but one with mesh). Primary immunosuppression in both groups at the time of transplantation was tacrolimus, but more patients in the LAP group were on sirolimus at the time of hernia, while more patients in the OP group were on prednisone at the time of hernia repair. All operations were completed with a laparoscopic approach; there were no conversions to open. Length of stay differed significantly between the 2 groups, with a mean of 5.4 days for the LAP group compared to 2.7 days in the OP group (0.0059). Complications occurred in 2 (15%) of the patients in the LAP group and 5 (36%) in the OP group. One patient in the LAP group required mesh removal to exclude causes of recurrent ascites, and 1 in the OP group for mesh infection. One (7.6%) of the patients in the LAP group developed a recurrence, compared to 29% (4) of the OP group (P =0.3259). In conclusion, laparoscopic incisional hernia repair is safe in patients after liver transplantation, with a low risk of infection or recurrence. Liver Transpl 13:1576–1581, 2007. © 2007 AASLD.
- 1 September 2007
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 11 (9) , 1188-1193
Surgical Management of Gallbladder Carcinoma: A Review
- 1 September 2007
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 11 (9) , 1188-1193
Surgical Management of Gallbladder Carcinoma: A Review
- Open Access
- 1 August 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (8) , 2039-2041
Diffuse Parenchymal Urine Leak After Kidney Transplantation Following Degloving Injury During Donor Nephrectomy
- 1 August 2007
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (8) , 2039-2041
Open AccessDiffuse Parenchymal Urine Leak After Kidney Transplantation Following Degloving Injury During Donor Nephrectomy